Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry

被引:10
|
作者
Corica, Bernadette [1 ,2 ,3 ]
Romiti, Giulio Francesco [1 ,2 ,3 ]
Proietti, Marco [1 ,2 ,4 ,5 ]
Mei, Davide Antonio [1 ,2 ,6 ]
Boriani, Giuseppe [6 ]
Chao, Tze-Fan [7 ,8 ,9 ]
Olshansky, Brian [10 ]
V. Huisman, Menno [11 ]
Lip, Gregory Y. H. [12 ,13 ]
机构
[1] Univ Liverpool, Liverpool John Moores Univ, Liverpool Ctr Cardiovasc Sci, Liverpool, England
[2] Liverpool Heart & Chest Hosp, Liverpool, England
[3] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy
[4] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[5] IRCCS Ist Clin Sci Maugeri, Geriatr Unit, Milan, Italy
[6] Univ Modena & Reggio Emilia, Cardiol Div, Dept Biomed Metab & Neural Sci, Policlin Modena, Modena, Italy
[7] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan
[8] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[9] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Taipei, Taiwan
[10] Univ Iowa Hosp & Clin, Dept Internal Med, Div Cardiol, Iowa City, IA USA
[11] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands
[12] Aalborg Univ, Danish Ctr Hlth Serv Res, Dept Clin Med, Aalborg, Denmark
[13] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, William Henry Duncan Bldg,6 W Derby St, Liverpool L7 8TX, England
关键词
BODY-MASS INDEX; WEIGHT; MANAGEMENT; RISK; ASSOCIATION; PREVENTION; REDUCTION; MORTALITY; PARADOX; DISEASE;
D O I
10.1016/j.mayocp.2023.07.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To explore the association between metabolic status, body mass index (BMI), and natural history of patients with atrial fibrillation (AF). Methods: The global, prospective GLORIA-AF Registry Phase II and III included patients with recent diagnosis of AF between November 2011 and December 2014 for Phase II and between January 2014 and December 2016 for Phase III. With this analysis, we categorized patients with AF according to BMI (normal weight [18.5 to 24.9 kg/m2], overweight [25.0 to 29.9 kg/m2], obese [30.0 to 60.0 kg/m2]) and metabolic status (presence of hypertension, diabetes, and hyperlipidemia). We analyzed risk of major outcomes using multivariable Cox regression analyses; the primary outcome was the composite of all-cause death and major adverse cardiovascular events. Results: There were 24,828 (mean age, 70.1 +/- 10.3 years; 44.6% female) patients with AF included. Higher BMI was associated with metabolically unhealthy status and higher odds of receiving oral anticoagulants and other treatments. Normal-weight unhealthy patients showed a higher risk of the primary composite outcome (adjusted hazard ratio [aHR], 1.20; 95% CI, 1.01 to 1.42) and thromboembolism, whereas a lower risk of cardiovascular death (aHR, 0.35; 95% CI, 0.14 to 0.88) and major adverse cardiovascular events (aHR, 0.56; 95% CI, 0.33 to 0.93) was observed in metabolically healthy obese individuals. Unhealthy metabolic groups were also associated with increased risk of major bleeding (aHR, 1.51 [95% CI, 1.04 to 2.20] and aHR, 1.96 [95% CI, 1.34 to 2.85] in overweight and Conclusion: Increasing BMI was associated with poor metabolic status and with more intensive treatment. Prognosis was heterogeneous between BMI groups, with metabolically unhealthy patients showing higher risk of adverse events. (c) 2023 THE AUTHORS. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research. This is an open access article under
引用
收藏
页码:927 / 939
页数:13
相关论文
共 50 条
  • [1] Adverse outcomes according to metabolic status in obese and overweight patients with atrial fibrillation: a report from the GLORIA-AF Phase II and III Registry
    Corica, B.
    Romiti, G. F.
    Proietti, M.
    Mei, D. A.
    Boriani, G.
    Chao, T. F.
    Olshansky, B.
    Huisman, M. V.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [2] PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY
    Paquette, Miney
    Huisman, Menno
    Lip, Gregory
    Diener, Hans-Christoph
    Dubner, Sergio
    Halperin, Jonathan
    Ma, Changsheng
    Rothman, Kenneth
    Teutsch, Christine
    Lu, Shihai
    Franca, Lionel Riou
    Zint, Kristina
    Bartels, Dorothee B.
    Nieuwlaat, Robby
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 374 - 374
  • [3] Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry
    Paquette, Miney
    Franca, Lionel Riou
    Teutsch, Christine
    Diener, Hans-Christoph
    Lu, Shihai
    Dubner, Sergio J.
    Ma, Chang Sheng
    Rothman, Kenneth J.
    Zint, Kristina
    Halperin, Jonathan L.
    Olshansky, Brian
    Huisman, Menno, V
    Lip, Gregory Y. H.
    Nieuwlaat, Robby
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (03): : 383 - 391
  • [4] Oral anticoagulant use and outcomes in Asian patients with atrial fibrillation in the GLORIA-AF Registry
    Romiti, G. F.
    Corica, B.
    Proietti, M.
    Mei, D. A.
    Frydenlund, J.
    Bisson, A.
    Boriani, G.
    Olshansky, B.
    Chan, Y. H.
    Huisman, M. V.
    Chao, T. F.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [5] Number of Previous Strokes and the Association With Clinical Outcomes of Patients With Atrial Fibrillation: Longitudinal Data From the GLORIA-AF Registry
    Lam, Steven Ho Man
    Romiti, Giulio Francesco
    Corica, Bernadette
    Bucci, Tommaso
    Olshansky, Brian
    Chao, Tze-Fan
    Huisman, Menno V.
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (02):
  • [6] Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III
    Romiti, Giulio Francesco
    Proietti, Marco
    Bonini, Niccolo
    Ding, Wern Yew
    Boriani, Giuseppe
    Huisman, Menno, V
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (12) : 2030 - 2041
  • [7] POLYPHARMACY IN A GLOBAL COHORT OF PATIENTS TAKING ANTICOAGULANTS FOR ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY
    Button, Dana
    Bayer, Valentina
    Olshansky, Brian
    Larsen, Peter
    Teutsch, Christine
    Patel, Sagar
    Huisman, Menno
    Lip, Gregory
    Kea, Bory
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1504 - 1504
  • [8] Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III
    Liu, Yang
    Chen, Yang
    Lam, Steven H. M.
    Huang, Bi
    Romiti, Giulio F.
    Alam, Uazman
    Chao, Tze Fan
    Olshansky, Brian
    Hong, Kui
    Huisman, Menno V.
    Lip, Gregory Y. H.
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5795 - 5804
  • [9] PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY
    McIntyre, William F.
    Conen, David
    Olshansky, Brian
    Halperin, Jonathan
    Hayek, Emil
    Huisman, Menno
    Lip, Gregory
    Lu, Shihai
    Healey, Jeff
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 413 - 413
  • [10] Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry
    Romiti, Giulio Francesco
    Corica, Bernadette
    Mei, Davide Antonio
    Frost, Frederick
    Bisson, Arnaud
    Boriani, Giuseppe
    Bucci, Tommaso
    Olshansky, Brian
    Chao, Tze-Fan
    Huisman, Menno, V
    Proietti, Marco
    Lip, Gregory Y. H.
    EUROPACE, 2023, 26 (01):